REMCs dedicated to the nation
Power Minister R K Singh on 28 February 2020 dedicated to the nation 11 Renewable Energy Management Centres (REMCs) for renewable energy integration.
Singh also inaugurated the Northern Region Renewable Energy Management Centre (NR-REMC) at a function in New Delhi.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22991-remcs-dedicated-to-the-nation.html
#REMCs #SLDCs #POSOCO #NLDC #RKSingh #CPSE

Global virus risk to maximum level
The World Health Organization on 28 February 2020 raised its global risk assessment of the new coronavirus to its highest level after the epidemic spread to sub-Saharan Africa and caused financial markets to plunge.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22990-global-virus-risk-to-maximum-level.html
#Global #WHO #TAG #SARS #COVID19 #microscope #virus

First glimpse of GISAT-1 satellite
The Indian Space Research Organisation (ISRO) on 28 February 2020 shared the first glimpse of Geo Imaging Satellite-1 (GISAT-1), that is scheduled to be launched on March 5 at 17:43 hours.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22989-first-glimpse-of-gisat-1-satellite.html
#GISAT1 #satellite #ISRO #GSLVF10 #ChandrayaanI

Wearable devices application rejected
The Indian Patent Office rejected Google’s application on wearable electronic devices, observing that it lacks inventive steps and the use and the method by which it is to be performed is not fully described in complete specification.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22988-wearable-devices-application-rejected.html
#Wearable #IPA #Google #satellite #OS

Biggest explosion since Big Bang
Astronomers have discovered the biggest explosion seen since the begining of the universe, originating from a super-massive black hole.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22987-biggest-explosion-since-big-bang.html
#BigBang #NASA #explosion #ICRAR #DrSimonaGiacintucci

New Prime Minister of Malaysia
Malaysia's kingnamed former interior minister Muhyiddin Yassin as the new prime minister on 29 February 2020 in a shock decision that sidelined old rivals Mahathir Mohamad and Anwar Ibrahim after a week of political turmoil.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/22986-new-prime-minister-of-malaysia.html
#Malaysia #NewPrimeMinister #UMNO #AnwarIbrahim #alliance

Evidence of virus-eating microorganisms
Scientists have found the first compelling evidence that two groups of ecologically important marine microorganisms could be eating viruses -- catching their "prey" and engulfing them, an advance that may lead to a better understanding of the flow of organic matter in the oceans.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/26109-evidence-of-virus-eating-microorganisms.html
#Evidence #virus #eatingmicroorganisms #UPSCOnlineClasses #OnlineClassses #IASOnlineclasses

Watch: Ebola Virus, KSG India
https://www.youtube.com/shorts/tkTWz68CajA

Today's Headlines - 23 August 2023
Maternal vaccine to prevent RSV in infants
GS Paper - 3 (Health and Diseases)

The United States became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.

More about the Vaccine

The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from 32 through 36 weeks of pregnancy, to protect infants from birth through six months.
It is the latest in a succession of medicines recently approved against the common microbe, which causes tens of thousands of hospitalizations among infants and the elderly in the United States every year.
Researchers have targeted an RSV vaccine since the 1960s, but the spates of shots that are emerging now were made possible thanks to a scientific breakthrough a decade ago.
RSV is a common cause of illness in children and infants are among those at highest risk for severe disease, which can lead to hospitalization.
This approval provides an option for healthcare providers and pregnant individuals to protect infants from this potentially life-threatening disease.
The approval follows a clinical trial involving some 7,000 pregnant women, which showed Pfizer's vaccine, called Abrysvo, reduced severe disease caused by RSV by 82 percent in babies from 0-3 months, and 69 percent from 0-6 months.
Abrysvo was previously approved by the FDA for adults aged 60 and over, as was another vaccine by drugmaker GSK, called Arexvy.
While RSV most often causes mild, cold-like symptoms in infants and young children, it can also lead to more serious outcomes such as pneumonia and bronchiolitis.

#upsc #news #headline #maternal #vaccine #RSV #healthanddiseases #country #pregnantwomen #severedisease #respiratory #syncytical #virus #vaccine #protectinfacts #commonmicrbe #spatesofshots #illness #healthcare #disease #succession #scientific #hospitalizations #medicines #women #abrysvo #FDA #Arexvy #symptoms #pneumonia #bronchiolitis